Cargando…

NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy

Oxalate nephropathy with renal failure is caused by multiple disorders causing hyperoxaluria due to either overproduction of oxalate (primary hyperoxaluria) or excessive absorption of dietary oxalate (enteric hyperoxaluria). To study the etiology of renal failure in crystal-induced kidney disease, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knauf, Felix, Asplin, John R., Granja, Ignacio, Schmidt, Insa M., Moeckel, Gilbert, David, Rachel, Flavell, Richard A., Aronson, Peter S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772982/ https://www.ncbi.nlm.nih.gov/pubmed/23739234 http://dx.doi.org/10.1038/ki.2013.207

Ejemplares similares

Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease
por: Ermer, Theresa, et al.
Publicado: (2017)

TRPV1 Hyperfunction Contributes to Renal Inflammation in Oxalate Nephropathy
por: Lu, Chien-Lin, et al.
Publicado: (2021)

Oxalate Nephropathy
por: Etta, Praveen K., et al.
Publicado: (2023)

Assessment of Plasma Oxalate Concentration in Patients With CKD
por: Pfau, Anja, et al.
Publicado: (2020)

Oxalate nephropathy: An important cause of renal failure after bariatric surgery
por: Nagaraju, S. P., et al.
Publicado: (2013)

Inhibitors of Calcium Oxalate Crystallization for the Treatment of Oxalate Nephropathies
por: Kletzmayr, Anna, et al.
Publicado: (2020)

Author Reply to Comment on “Assessment of Plasma Oxalate Concentration in Patients With CKD” by Oka et al.
por: Pfau, Anja, et al.
Publicado: (2021)

Diet-induced oxalate nephropathy
por: Clark, Barbara, et al.
Publicado: (2019)

Oxalate nephropathy: a review
por: Rosenstock, Jordan L, et al.
Publicado: (2021)

The NALP3/Cryopyrin-Inflammasome Complex is Expressed in LPS-Induced Ocular Inflammation
por: González-Benítez, José F., et al.
Publicado: (2008)

Vitamin C-Induced Oxalate Nephropathy
por: Lamarche, Jorge, et al.
Publicado: (2011)

Acute oxalate nephropathy associated with orlistat
por: Humayun, Youshay, et al.
Publicado: (2016)

Hydroxocobalamin as a Cause of Oxalate Nephropathy
por: Legrand, Matthieu
Publicado: (2018)

Primary Nonfunction of Renal Allograft Secondary to Acute Oxalate Nephropathy
por: Parasuraman, Ravi, et al.
Publicado: (2011)

Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
por: Lamkanfi, Mohamed, et al.
Publicado: (2009)

Ricin Toxin Activates the NALP3 Inflammasome
por: Lindauer, Meghan, et al.
Publicado: (2010)

The Relationship between NALP3 and Autoinflammatory Syndromes
por: Campbell, Lorna, et al.
Publicado: (2016)

The Role of Oxidative Stress and Inflammation in Acute Oxalate Nephropathy Associated With Ethylene Glycol Intoxication
por: Wilson, Gregory J., et al.
Publicado: (2018)

Oxalate nephropathy: A three-dimensional view
por: Ward, Ashley, et al.
Publicado: (2015)

Secondary Oxalate Nephropathy: A Systematic Review
por: Lumlertgul, Nuttha, et al.
Publicado: (2018)

Etiologies, Clinical Features, and Outcome of Oxalate Nephropathy
por: Buysschaert, Benoit, et al.
Publicado: (2020)

Oxalate Nephropathy in an Oxalobacter formigenes–Negative Subject
por: Nazzal, Lama, et al.
Publicado: (2020)

Warfarin-related nephropathy in a patient with mild IgA nephropathy on dabigatran and aspirin
por: Moeckel, Gilbert W., et al.
Publicado: (2013)

Azithromycin decreases NALP3 mRNA stability in monocytes to limit inflammasome-dependent inflammation
por: Lendermon, Elizabeth A., et al.
Publicado: (2017)

Rhein attenuates inflammation through inhibition of NF-κB and NALP3 inflammasome in vivo and in vitro
por: Ge, Hui, et al.
Publicado: (2017)

AEG-1 aggravates inflammation via promoting NALP3 inflammasome formation in murine endometriosis lesions
por: Zhao, Juan, et al.
Publicado: (2019)

Acute oxalate nephropathy caused by ethylene glycol poisoning
por: Seo, Jung Woong, et al.
Publicado: (2012)

Loss of Ecrg4 improves calcium oxalate nephropathy
por: Cabuzu, Daniela, et al.
Publicado: (2022)

GENETIC VARIATIONS IN NALP1 MRNA EXPRESSIONS IN HUMAN VITILIGO
por: Deo, Sudha S, et al.
Publicado: (2011)

Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity
por: Bednash, Joseph S., et al.
Publicado: (2017)

Rab GTPase Mediating Regulation of NALP3 in Colorectal Cancer
por: Tezcan, Gülçin, et al.
Publicado: (2020)

Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma
por: Purshouse, Karin, et al.
Publicado: (2019)

Acute Oxalate Nephropathy following Ingestion of Averrhoa bilimbi Juice
por: Nair, Sreeja, et al.
Publicado: (2014)

Peanut-induced acute oxalate nephropathy with acute kidney injury
por: Park, Hyeoncheol, et al.
Publicado: (2014)

Vitamin C-induced oxalate nephropathy: a case report
por: Gurm, Harmeet, et al.
Publicado: (2012)

A hidden cause of oxalate nephropathy: a case report
por: Mahmoud, Tala, et al.
Publicado: (2021)

Hydroxocobalamin-Induced Oxalate Nephropathy in a Patient With Smoke Inhalation
por: Evans, Jordan, et al.
Publicado: (2021)

Vitamin C-Induced Oxalate Nephropathy in a Septic Patient
por: Wissanji, Tasheen, et al.
Publicado: (2021)

The Beauty and the Beast: Bariatric Surgery and a Case of Oxalate Nephropathy
por: Carvalho, Renata, et al.
Publicado: (2023)

Purslane-induced oxalate nephropathy: case report and literature review
por: Wang, Xiangtuo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4pfivo5erm2o186hkcasbqib4i